MANNHEIM, Germany, March 03, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company ...
Find the latest Affimed N.V. AFMD analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
MANNHEIM, Germany, March 25, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer ...
Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.
FDMT 4D Molecular Therapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback